Cited by 1,317Cancer Genomics and DiagnosticsPancreatic and Hepatic Oncology ResearchChromatin Remodeling and Cancer

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

The patterns and dynamics of genomic instability in metastatic pancreatic cancer

Open access

Campbell, Peter J., Yachida, Shinichi, Mudie, Laura J., Stephens, Philip J., Pleasance, Erin D., Stebbings, Lucy A., Morsberger, Laura A., Latimer, Calli, McLaren, Stuart, Lin, Meng-Lay, McBride, David J., Varela, Ignacio, Nik-Zainal, Serena A., Leroy, Catherine, Jia, Mingming, Menzies, Andrew, Butler, Adam P., Teague, Jon W., Griffin, Constance A., Burton, John, Swerdlow, Harold, Quail, Michael A., Stratton, Michael R., Iacobuzio-Donahue, Christine, Futreal, P. Andrew·2010·Nature

DOI 10.1038/nature09460PMC PMC3137369

Open this paper in CoChat — free account

Abstract

Pancreatic cancer is an aggressive malignancy with a five-year mortality of 97-98%, usually due to widespread metastatic disease. Previous studies indicate that this disease has a complex genomic landscape, with frequent copy number changes and point mutations, but genomic rearrangements have not been characterized in detail. Despite the clinical importance of metastasis, there remain fundamental questions about the clonal structures of metastatic tumours, including phylogenetic relationships among metastases, the scale of ongoing parallel evolution in metastatic and primary sites, and how the tumour disseminates. Here we harness advances in DNA sequencing to annotate genomic rearrangements in 13 patients with pancreatic cancer and explore clonal relationships among metastases. We find that pancreatic cancer acquires rearrangements indicative of telomere dysfunction and abnormal cell-cycle control, namely dysregulated G1-to-S-phase transition with intact G2-M checkpoint. These initiate amplification of cancer genes and occur predominantly in early cancer development rather than the later stages of the disease. Genomic instability frequently persists after cancer dissemination, resulting in ongoing, parallel and even convergent evolution among different metastases. We find evidence that there is genetic heterogeneity among metastasis-initiating cells, that seeding metastasis may require driver mutations beyond those required for primary tumours, and that phylogenetic trees across metastases show organ-specific branches. These data attest to the richness of genetic variation in cancer, brought about by the tandem forces of genomic instability and evolutionary selection.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature09460

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Self-citation
Mapping short DNA sequencing reads and calling variants using mapping quality scores
Li, H., Ruan, J., & Durbin, R. (2008) · Genome Research · doi:10.1101/gr.078212.108 · Cited by 2,638
Recurring mutations found by sequencing an acute myeloid leukemia genome
Mardis, E. R., Ding, L., Dooling, D. J., Larson, D. E., McLellan, M. D., Chen, K., Koboldt, D. C., Fulton, R. S., Delehaunty, K. D., McGrath, S. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903840 · Cited by 2,219
A comprehensive catalogue of somatic mutations from a human cancer genome
Pleasance, E. D., Cheetham, R. K., Stephens, P. J., McBride, D. J., Humphray, S. J., Greenman, C. D., Varela, I., Lin, M.-L., Ordóñez, G. R., Bignell, G. R., et al. (2010) · Nature · doi:10.1038/nature08658 · Cited by 1,696
Self-citation
THE STABILITY OF BROKEN ENDS OF CHROMOSOMES IN ZEA MAYS
McClintock, B. (1941) · Genetics · doi:10.1093/genetics/26.2.234 · Cited by 1,605
Pancreatic cancer biology and genetics
Bardeesy, N. M., & DePinho, R. A. (2002) · Nature reviews. Cancer · doi:10.1038/nrc949 · Cited by 1,175
Parallel progression of primary tumours and metastases
Klein, C. A. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2627 · Cited by 1,161
Genome remodelling in a basal-like breast cancer metastasis and xenograft
Ding, L., Ellis, M. J., Li, S., Larson, D. E., Chen, K., Wallis, J. W., Harris, C. C., McLellan, M. D., Fulton, R. S., Fulton, L., et al. (2010) · Nature · doi:10.1038/nature08989 · Cited by 1,144
A small-cell lung cancer genome with complex signatures of tobacco exposure
Pleasance, E., Stephens, P. J., O’Meara, S., McBride, D. J., Meynert, A. M., Jones, D., Lin, M., Beare, D. M., Lau, K. W., Greenman, C., et al. (2009) · Nature · doi:10.1038/nature08629 · Cited by 1,076
Self-citation
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
Shah, S. P., Morin, R. D., Khattra, J. S., Prentice, L., Pugh, T. J., Burleigh, A., Delaney, A. D., Gelmon, K. A., Guliany, R., Senz, J., et al. (2009) · Nature · doi:10.1038/nature08489 · Cited by 1,063

Show all 30 references

Sorted by citations

Items 401–500 of 1,000

Emerging roles of the tumor-associated stroma in promoting tumor metastasis
Horimoto, Y., Polanska, U. M., Takahashi, Y., & Orimo, A. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.20631 · Cited by 65
Mre11-Sae2 and RPA Collaborate to Prevent Palindromic Gene Amplification
Deng, S., Yin, Y. A., Petes, T. D., & Symington, L. S. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.09.027 · Cited by 64
Clonal cooperativity in heterogenous cancers
Zhou, H., Neelakantan, D., & Ford, H. L. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.08.028 · Cited by 66
Temporal DNA-PK activation drives genomic instability and therapy resistance in glioma stem cells
Wang, Y., Xu, H., Liu, T., Huang, M., Butter, P.-P., Li, C., Zhang, L., Kao, G. D., Gong, Y., Maity, A. M., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.98096 · Cited by 65
Analysis of the tumor-initiating and metastatic capacity of PDX1-positive cells from the adult pancreas
Ischenko, I., Petrenko, O., & Hayman, M. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319911111 · Cited by 62
Electroporation and Immunotherapy—Unleashing the Abscopal Effect
Justesen, T. F., Orhan, A., Raskov, H., Nolsøe, C., & Gögenür, I. (2022) · Cancers · doi:10.3390/cancers14122876 · Cited by 67
An algorithmic approach for breakage-fusion-bridge detection in tumor genomes
Zakov, S., Kinsella, M., & Bafna, V. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220977110 · Cited by 58
Tumor-Reactive CD8+ T Cells in Metastatic Gastrointestinal Cancer Refractory to Chemotherapy
Turcotte, S., Gros, A., Tran, E., Lee, C. R., Wunderlich, J. R., Robbins, P. F., & Rosenberg, S. A. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1736 · Cited by 63
Human Cancer Classification: A Systems Biology- Based Model Integrating Morphology, Cancer Stem Cells, Proteomics, and Genomics
Idikio, H. (2011) · Journal of Cancer · doi:10.7150/jca.2.107 · Cited by 64
Genomic signatures as predictive biomarkers of homologous recombination deficiency in ovarian cancer
Vanderstichele, A., Busschaert, P., Olbrecht, S., Lambrechts, D., & Vergote, I. B. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.08.029 · Cited by 62
Pancreatic adenocarcinoma: insights into patterns of recurrence and disease behavior
Şahin, İ. H., Elias, H. K., Chou, J. F., Capanu, M., & O'Reilly, E. M. (2018) · BMC Cancer · doi:10.1186/s12885-018-4679-9 · Cited by 64
Mismatch repair status may predict response to adjuvant chemotherapy in resectable pancreatic ductal adenocarcinoma
Riazy, M., Kalloger, S. E., Sheffield, B. S., Peixoto, R. D., Li-Chang, H. H., Scudamore, C. H., Renouf, D. J., & Schaeffer, D. F. (2015) · Modern Pathology · doi:10.1038/modpathol.2015.89 · Cited by 63
SubcloneSeeker: a computational framework for reconstructing tumor clone structure for cancer variant interpretation and prioritization
Qiao, Y., Quinlan, A. R., Jazaeri, A. A., Verhaak, R. G. W., Wheeler, D. A., & Marth, G. (2014) · Genome biology · doi:10.1186/preaccept-1691129011290725 · Cited by 61
RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases
Romei, C., Ciampi, R., Casella, F., Tacito, A., Torregrossa, L., Ugolini, C., Basolo, F., Materazzi, G., Vitti, P., & Elisei, R. (2018) · Oncotarget · doi:10.18632/oncotarget.23986 · Cited by 62
Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor
Valetti, S., Maione, F., Mura, S., Stella, B., Desmaële, D., Noiray, M., Vergnaud, J., Vauthier, C., Cattel, L., Giraudo, E., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.039 · Cited by 67
Pancreatic cancer genomics
Chang, D. K.-F., Grimmond, S. M., & Biankin, A. V. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.12.001 · Cited by 62
Parkin deficiency contributes to pancreatic tumorigenesis by inducing spindle multipolarity and misorientation
Sun, X., Liu, M., Hao, J., Li, D., Luo, Y., Wang, X., Yang, Y., Li, F., Shui, W., Chen, Q., et al. (2013) · Cell Cycle · doi:10.4161/cc.24215 · Cited by 62
Surgical Management of Pancreatic Cancer—Pancreaticoduodenectomy
Donahue, T. R., & Reber, H. A. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.12.009 · Cited by 61
The combination of the expression of hexokinase 2 and pyruvate kinase M2 is a prognostic marker in patients with pancreatic cancer
Ogawa, H., Nagano, H., Konno, M., Eguchi, H., Koseki, J., Kawamoto, K., Nishida, N., Colvin, H. S., Tomokuni, A., Tomimaru, Y., et al. (2015) · Molecular and Clinical Oncology · doi:10.3892/mco.2015.490 · Cited by 61
Apoptosis and anergy of T cell induced by pancreatic stellate cells-derived galectin-1 in pancreatic cancer
Tang, D., Gao, J., Wang, S., Yuan, Z., Ye, N., Chong, Y., Xu, C., Jiang, X., Li, B., Yin, W., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-3233-5 · Cited by 61
Evaluation and consequences of heterogeneity in the circulating tumor cell compartment
Brouwer, A., Laere, B. D., Peeters, D. J. E., Peeters, M., Salgado, R., Dirix, L. Y., & Laere, S. V. (2016) · Oncotarget · doi:10.18632/oncotarget.8015 · Cited by 64
Liquid biopsy in pancreatic cancer: the beginning of a new era
Yadav, D. K., Bai, X., Yadav, R. K., Singh, A., Li, G., Ma, T., Chen, W., & Liang, T. (2018) · Oncotarget · doi:10.18632/oncotarget.24809 · Cited by 62
Genomic control of metastasis
Patel, S. A., Rodrigues, P., Wesolowski, L., & Vanharanta, S. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01127-6 · Cited by 57
Paradigm shift in oncology: targeting the immune system rather than cancer cells
Shekarian, T., Valsesia‐Wittmann, S., Caux, C., & Marabelle, A. (2015) · Mutagenesis · doi:10.1093/mutage/geu073 · Cited by 64
Adoptive T cell therapy promotes the emergence of genomically altered tumor escape variants
Kaluza, K. M., Thompson, J., Kottke, T. J., Gilmer, H. C. F., Knutson, D. L., & Vile, R. G. (2011) · International Journal of Cancer · doi:10.1002/ijc.26447 · Cited by 60
(Pro)renin receptor is crucial for Wnt/β-catenin-dependent genesis of pancreatic ductal adenocarcinoma
Shibayama, Y., Fujimori, T., Nguyen, G., Hirose, T., Totsune, K., Ichihara, A., Kitada, K., Nakano, D., Kobori, H., Kohno, M., et al. (2015) · Scientific Reports · doi:10.1038/srep08854 · Cited by 60
Self-citation
Implications of intratumour heterogeneity for treatment stratification
Crockford, A., Jamal‐Hanjani, M., Hicks, J. B., & Swanton, C. (2013) · The Journal of Pathology · doi:10.1002/path.4270 · Cited by 59
Drivers of dynamic intratumor heterogeneity and phenotypic plasticity
Biswas, A., & De, S. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00575.2020 · Cited by 60
Radiomics in hepatic metastasis by colorectal cancer
Granata, V., Fusco, R., Barretta, M. L., Picone, C., Avallone, A., Belli, A., Patrone, R., Ferrante, M., Cozzi, D., Grassi, R., et al. (2021) · Infectious Agents and Cancer · doi:10.1186/s13027-021-00379-y · Cited by 59
EXPRESSION OF CONCERN: Growth inhibition of pancreatic cancer cells by histone deacetylase inhibitor belinostat through suppression of multiple pathways including HIF, NFkB, and mTOR signaling in vitro and in vivo
Chien, W., Lee, D. H., Zheng, Y., Wuensche, P., Alvarez, R., Wen, D. L., Aribi, A. M., Thean, S. M., Doan, N., SAID, J. W., et al. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.22024 · Cited by 59
Metastatic Competence Can Emerge with Selection of Preexisting Oncogenic Alleles without a Need of New Mutations
Jacob, L. S., Vanharanta, S., Obenauf, A. C., Pirun, M., Viale, A. J., Socci, N. D., & Massagué, J. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0562 · Cited by 59
Strategies for discovering novel pancreatic cancer biomarkers
Chan, A., Diamandis, E. P., & Blasutig, I. M. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.09.025 · Cited by 61
Chromothripsis during telomere crisis is independent of NHEJ, and consistent with a replicative originPreprint
Cleal, K., Jones, R. E., Grimstead, J. W., Hendrickson, E. A., & Baird, D. M. (2019) · Genome Research · doi:10.1101/gr.240705.118 · Cited by 59
Mutational Landscape and Evolutionary Pattern of Liver and Brain Metastasis in Lung Adenocarcinoma
Jiang, T., Fang, Z., Tang, S., Cheng, R., Li, Y., Ren, S., Su, C., Min, W., Guo, X., Zhu, W., et al. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.10.128 · Cited by 60
Aneuploidy and complex genomic rearrangements in cancer evolution
Baker, T. M., Waise, S., Tarabichi, M., & Loo, P. V. (2024) · Nature Cancer · doi:10.1038/s43018-023-00711-y · Cited by 62
Molecular Characteristics of Pancreatic Ductal Adenocarcinoma
Ottenhof, N. A., de Wilde, R. F., Maitra, A., Hruban, R. H., & Offerhaus, G. J. A. (2011) · Pathology Research International · doi:10.4061/2011/620601 · Cited by 62
Hippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progression
Xie, D., Cui, J., Xia, T., Jia, Z., Wang, L., Wei, W.-F., Zhu, A., Gao, Y., Xie, K., & Quan, M. (2015) · Oncotarget · doi:10.18632/oncotarget.5772 · Cited by 58
The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF–ERK signaling
Maity, G., Haque, I., Ghosh, A., Dhar, G., Gupta, V. G., Sarkar, S., Azeem, I., McGregor, D. H., Choudhary, A., Campbell, D. R., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000333 · Cited by 59
Tissue specificity of DNA damage response and tumorigenesis
Sun, S., Osterman, M. D., & Li, M. (2019) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2019.0097 · Cited by 62
Accurate Reconstruction of the Temporal Order of Mutations in Neoplastic Progression
Sprouffske, K., Pepper, J. W., & Maley, C. C. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0374 · Cited by 57
Guidelines for DNA recombination and repair studies: Cellular assays of DNA repair pathways
Klein, H. L., Bačinskaja, G., Che, J., Cheblal, A., Elango, R., Epshtein, A., Fitzgerald, D. M., Gómez‐González, B., Khan, S. R., Kumar, S., et al. (2019) · Microbial Cell · doi:10.15698/mic2019.01.664 · Cited by 57
The Role of Dicentric Chromosome Formation and Secondary Centromere Deletion in the Evolution of Myeloid Malignancy
MacKinnon, R. N., & Campbell, L. J. (2011) · Genetics Research International · doi:10.4061/2011/643628 · Cited by 56
Positive lymph nodes do not metastasize
Engel, J., Emeny, R. T., & Hölzel, D. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9343-7 · Cited by 57
Molecular Pathogenesis of Pancreatic Cancer and Clinical Perspectives
Matthaios, D., Zarogoulidis, P., Balgkouranidou, I., Chatzaki, Ε., & Kakolyris, S. (2011) · Oncology · doi:10.1159/000334449 · Cited by 60
The potential utility of telomere‐related markers for cancer diagnosis
Heaphy, C. M., & Meeker, A. K. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01284.x · Cited by 57
The promise of circulating tumor cell analysis in cancer management
Mateo, J., Gerlinger, M., Rodrigues, D. N., & Bono, J. S. D. (2014) · Genome biology · doi:10.1186/s13059-014-0448-5 · Cited by 56
Clinical Integration of Next-Generation Sequencing Technology
Gullapalli, R. R., Lyons‐Weiler, M. A., Petrosko, P., Dhir, R., Becich, M. J., & LaFramboise, W. A. (2012) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2012.07.005 · Cited by 56
The role of quantitative mass spectrometry in the discovery of pancreatic cancer biomarkers for translational science
Ansari, D., Aronsson, L., Sasor, A., Welinder, C., Rezeli, M., Marko‐Varga, G., & Andersson, R. E. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-87 · Cited by 55
Pathways and Mechanisms that Prevent Genome Instability in Saccharomyces cerevisiae
Putnam, C. D., & Kolodner, R. D. (2017) · Genetics · doi:10.1534/genetics.112.145805 · Cited by 56
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas
Amato, E., Mafficini, A., Hirabayashi, K., Lawlor, R. T., Fassan, M., Vicentini, C., Barbi, S., Delfino, P., Sikora, K. O., Rusev, B. C., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5180 · Cited by 55
Precision medicine for metastatic colorectal cancer: an evolving era
Güler, İ., Aşkan, G., Klostergaard, J., & Şahin, İ. H. (2019) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1663174 · Cited by 56
Cyclin E expression is associated with high levels of replication stress in triple-negative breast cancer
Llobet, S. G., van der Vegt, B., Jongeneel, E., Bense, R. D., Zwager, M. C., Schröder, C. P., Everts, M., Fehrmann, R. S. N., de Bock, G. H., & van Vugt, M. A. T. M. (2020) · npj Breast Cancer · doi:10.1038/s41523-020-00181-w · Cited by 57
A river model to map convergent cancer evolution and guide therapy in RCC
Wei, E. Y., & Hsieh, J. J.-D. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2015.260 · Cited by 61
Fucosylation is a common glycosylation type in pancreatic cancer stem cell-like phenotypes
Terao, N. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i13.3876 · Cited by 54
Intratumoral heterogeneity in kidney cancer
Ricketts, C. J., & Linehan, W. M. (2014) · Nature Genetics · doi:10.1038/ng.2904 · Cited by 56
cAMP inhibits migration, ruffling and paxillin accumulation in focal adhesions of pancreatic ductal adenocarcinoma cells: Effects of PKA and EPAC
Burdyga, A., Conant, A. R., Haynes, L. P., Zhang, J., Jalink, K., Sutton, R., Neoptolemos, J. P., Costello, E., & Tepikin, A. V. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.06.011 · Cited by 54
Transcriptome analysis of pancreatic cancer reveals a tumor suppressor function for HNF1A
Hoskins, J. W., Jia, J., Flández, M., Parikh, H. M., Xiao, W., Collins, I. J., Emmanuel, M. A., Ibrahim, A. M., Powell, J. I., Zhang, L., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu193 · Cited by 54
Endogenous DNA Double-Strand Breaks during DNA Transactions: Emerging Insights and Methods for Genome-Wide Profiling
Bouwman, B. A. M., & Crosetto, N. (2018) · Genes · doi:10.3390/genes9120632 · Cited by 65
Intratumor heterogeneity inferred from targeted deep sequencing as a prognostic indicator
Oh, B. Y., Shin, H., Yun, J. W., Kim, K., Kim, J.-H., Bae, J. S., Cho, Y. B., Lee, W. Y., Yun, S. H., Park, Y. A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-41098-0 · Cited by 54
Pre-clinical Models of Metastasis in Pancreatic Cancer
Miquel, M., Zhang, S., & Pilarsky, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.748631 · Cited by 53
A Meta Analysis of Pancreatic Microarray Datasets Yields New Targets as Cancer Genes and Biomarkers
Goonesekere, N. C. W., Wang, X., Ludwig, L., & Guda, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093046 · Cited by 54
Somatic Mutagenesis with a Sleeping Beauty Transposon System Leads to Solid Tumor Formation in Zebrafish
McGrail, M. A., Hatler, J. M., Kuang, X., Liao, H.-K., Nannapaneni, K., Watt, K. E. N., Uhl, J. D., Largaespada, D. A., Vollbrecht, E., Scheetz, T. E., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018826 · Cited by 53
Design and Function of Engineered Protein Nanocages as a Drug Delivery System for Targeting Pancreatic Cancer Cells via Neuropilin-1
Murata, M., Narahara, S., Kawano, T., Hamano, N., Piao, J. S., Kang, J., Ohuchida, K., Murakami, T., & Hashizume, M. (2015) · Molecular Pharmaceutics · doi:10.1021/mp5007129 · Cited by 53
APOBEC3 Cytidine Deaminases in Double-Strand DNA Break Repair and Cancer Promotion
Nowarski, R., & Kotler, M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0728 · Cited by 54
Recapitulation of complex transport and action of drugs at the tumor microenvironment using tumor-microenvironment-on-chip
Han, B., Qu, C., Park, K., Konieczny, S. F., & Korc, M. (2016) · Cancer Letters · doi:10.1016/j.canlet.2015.12.003 · Cited by 53
A population genetics perspective on the determinants of intra-tumor heterogeneity
Hu, Z., Sun, R., & Curtis, C. N. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.03.001 · Cited by 54
New Developments in the Molecular Mechanisms of Pancreatic Tumorigenesis
Felsenstein, M., Hruban, R. H., & Wood, L. D. (2017) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000172 · Cited by 59
A genetic roadmap of pancreatic cancer: still evolving
Notta, F., Hahn, S. A., & Real, F. X. (2017) · Gut · doi:10.1136/gutjnl-2016-313317 · Cited by 54
The genetic complexity of common cancers and the promise of personalized medicine: is there any hope?
Arnedos, M., Vielh, P. R., Soria, J., & André, F. (2013) · The Journal of Pathology · doi:10.1002/path.4276 · Cited by 51
Diffusion-Weighted MRI and Diffusion Kurtosis Imaging to Detect RAS Mutation in Colorectal Liver Metastasis
Granata, V., Fusco, R., Risi, C., Ottaiano, A., Avallone, A., Stefano, A. D., Grimm, R., Grassi, R., Brunese, L., Izzo, F., et al. (2020) · Cancers · doi:10.3390/cancers12092420 · Cited by 52
Genomic instability in pancreatic adenocarcinoma: a new step towards precision medicine and novel therapeutic approaches
Şahin, İ. H., Lowery, M. A., Stadler, Z. K., Salo‐Mullen, E. E., Iacobuzio–Donahue, C. A., Kelsen, D. P., & O'Reilly, E. M. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1153424 · Cited by 56
Self-citation
Master Regulators of Oncogenic KRAS Response in Pancreatic Cancer: An Integrative Network Biology Analysis
Sivakumar, S., de Santiago, I., Chlon, L., & Markowetz, F. M. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002223 · Cited by 51
Epigenetic Alterations in Pancreatic Cancer Metastasis
Wang, S. S., Xu, J., Ji, K. Y., & Hwang, C. (2021) · Biomolecules · doi:10.3390/biom11081082 · Cited by 50
NCI's provocative questions on cancer: some answers to ignite discussion
Blagosklonny, M. V. (2011) · Oncotarget · doi:10.18632/oncotarget.432 · Cited by 51
Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response
Liu, X., George, G. C., Tsimberidou, A. M., Naing, A., Wheler, J. J., Kopetz, S., Fu, S., Piha-Paul, S. A., Eng, C., Falchook, G. S., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1701-3 · Cited by 52
Systems biology of cancer: entropy, disorder, and selection-driven evolution to independence, invasion and “swarm intelligence”
Tarabichi, M., Antoniou, A., Saiselet, M., Pita, J. M. G., Andry, G., Dumont, J. E., Detours, V., & Maenhaut, C. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9431-y · Cited by 51
Immortalization and malignant transformation of Eukaryotic cells
Stepanenko, A. A., & KAVSAN, V. M. (2012) · Cytology and Genetics · doi:10.3103/s0095452712020041 · Cited by 52
Proteome of formalin‐fixed paraffin‐embedded pancreatic ductal adenocarcinoma and lymph node metastases
Naidoo, K., Jones, R. C., Dmitrović, B., Wijesuriya, N., Kocher, H. M., Hart, I. R., & Crnogorac‐Jurcevic, T. (2011) · The Journal of Pathology · doi:10.1002/path.3959 · Cited by 51
Inferring mutational timing and reconstructing tumour evolutionary histories
Turajlic, S., McGranahan, N., & Swanton, C. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.03.005 · Cited by 53
The role of cancer stem cells in tumor heterogeneity and resistance to therapy
Konrad, C. V., Murali, R., Varghese, B. A., & Nair, R. (2016) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2016-0079 · Cited by 51
Not Everyone Fits the Mold: Intratumor and Intertumor Heterogeneity and Innovative Cancer Drug Design and Development
Dzobo, K., Senthebane, D. A., Thomford, N. E., Rowe, A., Dandara, C., & Parker, M. I. (2018) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2017.0174 · Cited by 54
Catastrophic Endgames: Emerging Mechanisms of Telomere-Driven Genomic Instability
Cleal, K., & Baird, D. M. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.02.001 · Cited by 54
Stereotactic Body Radiotherapy for Oligometastasis
Correa, R. J. M., Salama, J. K., Milano, M. T., & Palma, D. A. (2016) · The Cancer Journal · doi:10.1097/ppo.0000000000000202 · Cited by 50
Differential expression of neurogenes among breast cancer subtypes identifies high risk patients
Fernández‐Nogueira, P., Bragado, P., Almendro, V., Ametller, E., Ríos, J., Choudhury, S. A., Mancino, M., & Gascón, P. (2015) · Oncotarget · doi:10.18632/oncotarget.6543 · Cited by 48
Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis
Iqbal, W., Alkarim, S., Al-Hejin, A. M., Mukhtar, H., & Saini, K. S. (2016) · Oncotarget · doi:10.18632/oncotarget.10942 · Cited by 50
Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer
Takai, E., & Yachida, S. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i38.8480 · Cited by 53
Self-citation
Role of the DEAD-box RNA helicase DDX5 (p68) in cancer DNA repair, immune suppression, cancer metabolic control, virus infection promotion, and human microbiome (microbiota) negative influence
Li, F., Ling, X., Chakraborty, S., Fountzilas, C. K., Wang, J., Jamroze, A., Liu, X., Kaliński, P., & Tang, D. G. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02787-x · Cited by 51
Next-generation sequencing reveals the secrets of the chronic lymphocytic leukemia genome
Ramsay, A. J., Martínez‐Trillos, A., Jares, P., Rodrı́guez, D., Kwarciak, A., & Quesada, V. (2012) · Clinical & Translational Oncology · doi:10.1007/s12094-012-0922-z · Cited by 50
An enhanced genetic model of colorectal cancer progression history
Yang, L., Wang, S., Lee, J. J.-K., Lee, S., Lee, E., Shinbrot, E., Wheeler, D. A., Kucherlapati, R., & Park, P. J. (2019) · Genome biology · doi:10.1186/s13059-019-1782-4 · Cited by 48
Pancreatic Ductal Adenocarcinoma: Molecular Pathology and Predictive Biomarkers
Taherian, M., Wang, H., & Wang, H. (2022) · Cells · doi:10.3390/cells11193068 · Cited by 52
Studying cancer metastasis: Existing models, challenges and future perspectives
van Marion, D. M. S., Domańska, U., Timmer‐Bosscha, H., & Walenkamp, A. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.08.009 · Cited by 48
Cancer sequencing unravels clonal evolution
Caldas, C. (2012) · Nature Biotechnology · doi:10.1038/nbt.2213 · Cited by 48
New insights for early intervention and detection
Costello, E., & Neoptolemos, J. P. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.214 · Cited by 47
Road to early detection of pancreatic cancer: Attempts to utilize epigenetic biomarkers
Fukushige, S., & Horii, A. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.03.022 · Cited by 47
Whole genome RNA expression profiling of endoscopic biliary brushings provides data suitable for biomarker discovery in cholangiocarcinoma
Chapman, M. H., Tidswell, R., Dooley, J. S., Sandanayake, N. S., Cérec, V., Deheragoda, M. G., Lee, A. J. X., Swanton, C., Andreola, F., & Pereira, S. P. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.022 · Cited by 47
mRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients
Mostert, B., Sieuwerts, A. M., Vries, J. B., Kraan, J., Lalmahomed, Z. S., van Galen, A., van der Spoel, P., de Weerd, V., Ramírez‐Moreno, R., Smid, M., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.01.001 · Cited by 47
Cancer Stem Cells, Bone and Tumor Microenvironment: Key Players in Bone Metastases
Roato, I., & Ferracini, R. (2018) · Cancers · doi:10.3390/cancers10020056 · Cited by 49
Fucoidan-coated coral-like Pt nanoparticles for computed tomography-guided highly enhanced synergistic anticancer effect against drug-resistant breast cancer cells
Kang, S., Kang, K., Chae, A., Kim, Y., Jang, H., & Min, D. (2019) · Nanoscale · doi:10.1039/c9nr04495g · Cited by 47
Phenylboronic acid modified nanoparticles simultaneously target pancreatic cancer and its metastasis and alleviate immunosuppression
Lu, Z., Long, Y., Wang, Y., Wang, X., Xia, C., Li, M., Zhang, Z., & He, Q. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.05.014 · Cited by 46
Describing Sequencing Results of Structural Chromosome Rearrangements with a Suggested Next-Generation Cytogenetic Nomenclature
Ordulu, Z., Wong, K. E., Currall, B., Ivanov, A. R., Pereira, S., Althari, S., Gusella, J. F., Talkowski, M. E., & Morton, C. C. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.03.020 · Cited by 46

Authors: Campbell, P. J., Yachida, S., Mudie, L. J., Stephens, P. J., Pleasance, E. D., Stebbings, L. A., Morsberger, L. A., Latimer, C., McLaren, S., Lin, M.-L., McBride, D. J., Varela, I., Nik-Zainal, S. A., Leroy, C., Jia, M., Menzies, A., Butler, A. P., Teague, J. W., Griffin, C. A., Burton, J., Swerdlow, H., Quail, M. A., Stratton, M. R., Iacobuzio-Donahue, C., & Futreal, P. A.
Affiliations: University of Cambridge (GB)
Johns Hopkins University (US)
Wellcome Sanger Institute (GB)
Institute of Cancer Research (GB)
Corresponding author: Futreal, P. Andrew
ORCID: Campbell, Peter J.
Yachida, Shinichi
Pleasance, Erin D.
Latimer, Calli
McLaren, Stuart
McBride, David J.
Varela, Ignacio
Jia, Mingming
Menzies, Andrew
Teague, Jon W.
Swerdlow, Harold
Quail, Michael A.
Stratton, Michael R.
Futreal, P. Andrew
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2010-10
Volume: 467
Issue: 7319
Pages: 1109-1113
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature09460
PMC: PMC3137369
OpenAlex: W2066254965
Cited by: 1,317
References: 30
Citations by year: 2026: 10 · 2025: 31 · 2024: 33 · 2023: 51 · 2022: 47 · 2021: 86 · 2020: 69 · 2019: 72 · 2018: 75 · 2017: 117 · 2016: 104 · 2015: 119 · 2014: 153 · 2013: 109 · 2012: 135
FWCI: 34.92
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: Skip Viragh Foundation
Uehara Memorial Foundation
Wellcome Trust (077012/Z/05/Z, 088340, 093867, WT088340MA)
National Institutes of Health
National Cancer Institute (R01CA140599, K08CA106610, CA140599, CA106610)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords: pancreatic cancer, metastasis, genomic instability, chromosomal rearrangements, clonal evolution, telomere dysfunction, G1/S checkpoint, copy number alterations, tumor progression, early detection, therapeutic target, interpatient heterogeneity, tumour dissemination, somatic mutations, GATA4, GATA3
MeSH terms: Adenocarcinoma, Cell Cycle, Clone Cells, DNA Mutational Analysis, Humans, Liver Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Organ Specificity, Pancreatic Neoplasms, Mutagenesis, Telomere, Disease Progression, Cell Lineage, Evolution, Molecular, Genomic Instability, Genes, Neoplasm

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The patterns and dynamics of genomic instability in metastatic pancreatic cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks